T. Rowe Price Investment Management Inc. Has $22.49 Million Holdings in Phreesia, Inc. (NYSE:PHR)

T. Rowe Price Investment Management Inc. decreased its position in Phreesia, Inc. (NYSE:PHR) by 45.1% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 893,716 shares of the company’s stock after selling 734,249 shares during the period. T. Rowe Price Investment Management Inc. owned about 1.54% of Phreesia worth $22,486,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in shares of Phreesia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock valued at $121,349,000 after purchasing an additional 61,048 shares in the last quarter. Greenhouse Funds LLLP lifted its stake in Phreesia by 27.9% in the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock worth $72,307,000 after acquiring an additional 626,579 shares in the last quarter. Franklin Resources Inc. boosted its position in Phreesia by 0.8% during the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock worth $37,982,000 after acquiring an additional 11,986 shares during the period. Charles Schwab Investment Management Inc. grew its stake in Phreesia by 10.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 493,448 shares of the company’s stock valued at $12,415,000 after acquiring an additional 46,209 shares in the last quarter. Finally, Peregrine Capital Management LLC increased its holdings in shares of Phreesia by 0.8% in the 4th quarter. Peregrine Capital Management LLC now owns 319,327 shares of the company’s stock valued at $8,034,000 after purchasing an additional 2,531 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.

Phreesia Stock Up 0.6 %

Shares of Phreesia stock opened at $24.73 on Friday. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53. The stock has a market capitalization of $1.45 billion, a P/E ratio of -16.82 and a beta of 0.82. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a 50 day moving average price of $25.51 and a two-hundred day moving average price of $24.39.

Wall Street Analysts Forecast Growth

PHR has been the subject of several research reports. Piper Sandler restated an “overweight” rating and set a $33.00 price target (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. Citigroup boosted their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a report on Friday, January 10th. DA Davidson cut their price objective on Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a report on Monday, April 14th. Canaccord Genuity Group lifted their price objective on Phreesia from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Thursday, March 13th. Finally, KeyCorp dropped their target price on Phreesia from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 16th. Twelve equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Phreesia presently has an average rating of “Buy” and an average target price of $31.33.

Insider Buying and Selling

In other Phreesia news, CFO Balaji Gandhi sold 28,759 shares of the business’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $30.00, for a total transaction of $862,770.00. Following the completion of the transaction, the chief financial officer now owns 116,174 shares of the company’s stock, valued at $3,485,220. The trade was a 19.84 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Allison C. Hoffman sold 6,556 shares of the company’s stock in a transaction dated Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $180,158.88. Following the sale, the general counsel now owns 152,361 shares of the company’s stock, valued at $4,186,880.28. This trade represents a 4.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 146,930 shares of company stock valued at $4,067,102. Company insiders own 5.80% of the company’s stock.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.